Pellat-Deceunynck C - Search Results

1

Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells.

Menoret E, Gomez-Bougie P, Geffroy-Luseau A, Daniels S, Moreau P, Le Gouill S, Harousseau JL, Bataille R, Amiot M, Pellat-Deceunynck C. Menoret E, et al. Blood. 2006 Aug 15;108(4):1346-52. doi: 10.1182/blood-2005-12-007971. Epub 2006 Apr 25. Blood. 2006. PMID: 16638930 Free article.

2

Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells.

Pellat-Deceunynck C, Bataille R, Robillard N, Harousseau JL, Rapp MJ, Juge-Morineau N, Wijdenes J, Amiot M. Pellat-Deceunynck C, et al. Blood. 1994 Oct 15;84(8):2597-603. Blood. 1994. PMID: 7522634 Free article.

3

Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization.

Pellat-Deceunynck C, Barillé S, Puthier D, Rapp MJ, Harousseau JL, Bataille R, Amiot M. Pellat-Deceunynck C, et al. Cancer Res. 1995 Aug 15;55(16):3647-53. Cancer Res. 1995. PMID: 7543019

4

Human myeloma cell lines as a tool for studying the biology of multiple myeloma: a reappraisal 18 years after.

Pellat-Deceunynck C, Amiot M, Bataille R, Van Riet I, Van Camp B, Omede P, Boccadoro M. Pellat-Deceunynck C, et al. Blood. 1995 Nov 15;86(10):4001-2. Blood. 1995. PMID: 7579375 Free article. No abstract available.

5

CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation.

Pellat-Deceunynck C, Amiot M, Robillard N, Wijdenes J, Bataille R. Pellat-Deceunynck C, et al. Cancer Res. 1996 Apr 15;56(8):1909-16. Cancer Res. 1996. PMID: 8620513

6

Ectopic secretion of osteocalcin, the major non-collagenous bone protein, by the myeloma cell line NCI-H929.

Barille S, Pellat-Deceunynck C, Bataille R, Amiot M. Barille S, et al. J Bone Miner Res. 1996 Apr;11(4):466-71. doi: 10.1002/jbmr.5650110407. J Bone Miner Res. 1996. PMID: 8992877

7

CD40 and CD95 induce programmed cell death in the human myeloma cell line XG2.

Bergamo A, Bataille R, Pellat-Deceunynck C. Bergamo A, et al. Br J Haematol. 1997 Jun;97(3):652-5. doi: 10.1046/j.1365-2141.1997.1032919.x. Br J Haematol. 1997. PMID: 9207415 Free article.

8

CD28, a marker associated with tumoral expansion in multiple myeloma.

Robillard N, Jego G, Pellat-Deceunynck C, Pineau D, Puthier D, Mellerin MP, Barillé S, Rapp MJ, Harousseau JL, Amiot M, Bataille R. Robillard N, et al. Clin Cancer Res. 1998 Jun;4(6):1521-6. Clin Cancer Res. 1998. PMID: 9626472

9

The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma.

Pellat-Deceunynck C, Barillé S, Jego G, Puthier D, Robillard N, Pineau D, Rapp MJ, Harousseau JL, Amiot M, Bataille R. Pellat-Deceunynck C, et al. Leukemia. 1998 Dec;12(12):1977-82. doi: 10.1038/sj.leu.2401211. Leukemia. 1998. PMID: 9844928

10

Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy.

Puthier D, Pellat-Deceunynck C, Barillé S, Robillard N, Rapp MJ, Juge-Morineau N, Harousseau JL, Bataille R, Amiot M. Puthier D, et al. Leukemia. 1999 Feb;13(2):289-94. doi: 10.1038/sj.leu.2401302. Leukemia. 1999. PMID: 10025904 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters